Abliva

Mitocon's Mitochondrial Diseases Conference
2022-10-07 - 2022-10-08 | Holiday Inn Rome EUR Parco dei Medici, Rome, Italy
In October, Abliva will attend the Italian patient organization Mitocon’s annual Mitochondrial Diseases Conference in Rome, Italy.
On October 8, Abliva’s Chief Medical Officer Magnus Hansson will give the talk: An adaptive, clinical Phase 2/3 study evaluating the efficacy of KL1333 in adult primary mitochondrial disease patients in Session 5: Challenges and pitfalls in clinical trials design – presentations and round table discussion.

Nordic Life Science Days 2022
2022-09-28 - 2022-09-29 | Malmömässan, Mässgatan 6, Malmö, 215 32, Sweden
Abliva will attend the Nordic Life Science Days in Malmö, Sweden, on September 28-29, 2022.
CEO Ellen Donnelly will be presenting the company at 11:00 CEST on Sep 29.

Aktiedagen Lund
2022-09-26 | Elite Hotel Ideon, Scheelevägen 27, Lund, 22363, Sweden
On September 26 (Monday), 2022, Abliva will attend Aktiespararna’s Aktiedagen Lund, at Elite Hotel Ideon.
CEO Ellen Donnelly will present the company at 4 p.m. CEST. See below for more info and registration.

Hadean Investor Day
2022-09-21 | Oslo, Norway
More info to come.

mitoNice
2022-09-15 - 2022-09-17 | Nice Acropolis Congress Center, Nice, France
In September, Abliva will attend mitoNice, an international congress dedicated to Mitochondrial Medicine.

Aktiespararna's Digital Temadag - Life Science
2022-08-31 15:00 - 20:40 (Europe/Stockholm) | Virtual
Abliva will be attending Aktiespararna’s Digital Temadag – Life Science, on Aug 31, 2022.
CEO Ellen Donnelly will present the company at 6:20 p.m. CEST. Follow link below for further information.

Bioblast 2022: Inaugural Conference of Bioenergetics Communications
2022-06-29 - 2022-06-30 | Congress Innsbruck, Rennweg 3, Innsbruck, Austria
On June 29-30, Abliva will participate at Bioblast 2022: Inaugural Conference of Bioenergetics Communications in Innsbruck, Austria.
Abliva’s Communications Officer & Lab Manager, Eleonor Åsander Frostner, will present a summary of the company’s recent preprint publication “Towards a treatment for mitochondrial disease: current compounds in clinical development“.

Fireside Chat in Stockholm
2022-06-21 16:00 - 18:00 | Erik Penser Bank, Apelbergsgatan 27, Stockholm, Sweden
In light of our recent announcement and the continued developments in the company, we would like to invite shareholders and interested investors to an informal gathering to hear more about the path forward directly from Ellen Donnelly (CEO) and the Abliva team. We hope you will join us in Stockholm during the Midsummer week to hear an update on the company, learn more about the ongoing rights issue, and ask your most pressing questions.
The event is free of charge, and wine and snacks will be served. As seats are limited, please respond quickly to reserve your space.
Stockholm, 21 June, 16:00 – 18:00 p.m. CEST:
Erik Penser Bank, Apelbergsgatan 27.
Please respond to anmalan@abliva.com to reserve your space.

Fireside Chat in Lund
2022-06-20 16:00 - 18:00 | Restaurang Inspira, Scheeletorget 1, Lund, Sweden
In light of our recent announcement and the continued developments in the company, we would like to invite shareholders and interested investors to an informal gathering to hear more about the path forward directly from Ellen Donnelly (CEO) and the Abliva team. We hope you will join us in Lund during the Midsummer week to hear an update on the company, learn more about the ongoing rights issue, and ask your most pressing questions.
The event is free of charge, and wine and snacks will be served. As seats are limited, please respond quickly to reserve your space.
Lund, 20 June, 16:00 – 18:00 p.m. CEST:
Restaurang Inspira, Medicon Village, Scheeletorget 1.
Please respond to anmalan@abliva.com to reserve your space.

UMDF's Mitochondrial Medicine Symposium
2022-06-08 - 2022-06-11 | JW Marriott Phoenix Desert Ridge Resort & Spa, Phoenix, AZ, United States
Abliva will participate at the United Mitochondrial Disease Foundation’s Mitochondrial Medicine Symposium in Phoenix, Arizona.
Abliva’s CMO, Magnus Hansson, will participate in a panel discussion on clinical trials together with Baylor College of Medicine, Cyclerion Therapeutics, and Khondrion, on Friday June 10.

Audiocast with teleconference
2022-06-01 14:00 - 15:00 | Virtual
Abliva invites to a conference call and an online presentation on June 1, 2022, at 14:00 CEST. Abliva’s CEO Ellen Donnelly, CMO Magnus Hansson and CFO Catharina Johansson will inform about the financing and implementation of KL1333 Phase 2/3 study and answer questions. The presentation will be held in English.
After the presentation, there will be a Q&A session. Questions can be asked directly during the teleconference or by sending an email to ir@abliva.com
See link to audiocast below.
Dial-in numbers to conference call:
SE: +46850558355
UK: +443333009274
US: +16467224956

Mitochondria-Targeted Drug Development Summit
2022-02-22 - 2022-02-24 | Hyatt Regency Boston/Cambridge, 575 Memorial Dr, Cambridge, Massachusetts, 02139, United States
Abliva will attend and present at the Mitochondria-Targeted Drug Development Summit in Boston, MA, USA. The event will be held on 22 – 24 February 2022.
CEO Ellen Donnelly will be presenting in the session Patient-Focused Drug Development for Mitochondrial Disease.
Synopsis:

Highlighting the impact of patient input on research and development at Abliva
Providing an overview of the multiple therapeutic options for mitochondrial disease being pursued at Abliva
Presenting placebo controlled PMD patient data from our lead asset, KL1333

Mitochondrial Medicine - Therapeutic Development
2021-11-30 - 2021-12-02 | Virtual
Abliva will attend the virtual conference Mitochondrial Medicine – Therapeutic Development, organized by the Wellcome Connecting Science located at the Wellcome Genome Campus in the UK, on 30 Nov – 2 Dec 2021.
Abliva’s CMO, Magnus Hansson, has been invited to give a presentation on the topic Academia-pharma interplay in drug development, during Session 1: Mitochondrial Medicine – pharma and funding perspectives.

BioStock Life Science Summit
2021-10-20 - 2021-10-21 | Virtual
Abliva will attend the BioStock Life Science Summit 2021.
CEO Ellen Donnelly will be presenting the company on 20 October at 2:00 p.m. CEST.

Kvinnokvällen (Women's night) Malmö
2021-10-19 | Virtual
Abliva will attend Aktiespararna’s Kvinnokvällen Malmö, on 19 October 2021..
CEO Ellen Donnelly will be presenting the company at 7:30 p.m. CEST.

Mitochondrial Diseases Conference 2021
2021-10-15 - 2021-10-16 | Virtual
Italian patient organization Mitocon arranges this year’s Mitochondrial Diseases Conference in virtual.
Abliva’s Chief Medical Officer, Magnus Hansson, will give a flash presentation and join round table discussions at the meeting.

21st Annual Biotech in Europe Forum (BEF) (digital)
2021-10-07 - 2021-10-08 | Basel, Basel, Switzerland
Abliva will attend the digital/hybrid event: 21st Annual Biotech in Europe Forum (BEF), on 7 – 8 October 2021.

Fireside chat
2021-09-28 - 2021-09-29 | MA
Abliva would like to invite interested shareholders and investors to a fun and informal “Fireside Chat” with the company’s CEO, Ellen Donnelly, and members of the Abliva team, in Stockholm (28 September) and Lund (29 September).

After a long stretch of stringent travel restrictions and two-dimensional zoom presentations, we would like to invite Abliva shareholders and interested investors to an informal gathering to hear more about the Abliva strategy and direction directly from Ellen Donnelly (CEO) and the Abliva team. Ellen, an American, joined the company as CEO in February 2021 but has been unable to visit due to COVID restrictions. We hope you will join us in Stockholm or Lund at the end of the month to hear an update on the company and ask your most pressing questions. Seats are limited so please respond quickly to reserve your space.
Stockholm (center): 28 September, 5:00 – 6:00 p.m. CEST.
Lund: 29 September, 4:30 – 5.30 p.m. CEST.
Please respond to anmalan@abliva.com to reserve your space. Meeting details will be provided after registration.

World Mitochondrial Disease Week
2021-09-19 - 2021-09-25 | MA
Every year, during the third week of September, the World Mitochondrial Disease Week (WMDW) is being held. This global, important, and rapidly growing event was an initiative from patient organization International mito-patients (IMP).

Mito-race
2021-09-12 - 2021-09-18 | Virtual
Now you can sign up for LHON Eye Society’s 5 km Mito-race, either in Stockholm on 15 September, or the virtual one on 12 – 18 September. The event takes place in connection to the World Mitochondrial Disease Week (19 – 25 September).

Kvinnokvällen Göteborg
2021-08-31 16:00 - 21:00 | Park Avenue Hotel, Kungsportsavenyn 36-38, Gothenburg, 411 36, Sweden
Abliva will participate at Aktiespararna’s Kvinnokvällen (Women’s night) in Gothenburg, on 31 August 2021.
CEO Ellen Donnelly will be presenting the company digitally, at 6 p.m. CEST.
Follow the event live here: aktiespararna.se/tv/live

UMDF Mitochondrial Medicine
2021-06-24 - 2021-06-26 | Virtual
The US patient organization United Mitochondrial Disease Foundation (UMDF) is hosting its annual Mitochondrial Medicine Symposium, this year virtual, in June.
Abliva will participate in the scientific sessions:

Chief Medical Officer, Magnus Hansson, will constitute one of the panelists, on Friday 25 June, at 1:50 p.m. EST, in the Clinical Trials Panel #2 Discussion, together with representatives from Baylor College of Medicine, Cyclerion Therapeutics, and Khondrion.
Data from Abliva’s Phase 1a/b study with KL1333 will be presented on an e-Poster, available to registered participants throughout the event.

Redeye Investor Forum Online
2021-05-20 13:00 - 14:00 | Virtual
CEO Ellen Donnelly will present the company at 1:20 p.m. CEST.

Redeye Orphan Drugs
2021-04-28 09:00 - 12:00 | Virtual
Abliva will participate at Redeye’s seminar on ‘Drug development in orphan indications.’
CEO Ellen Donnelly will be presenting the company at 10:55 a.m. CEST. Follow link below for further details and live webcast.

European Biotech Investor Days
2021-04-07 18:30 - 19:00 | Virtual
Abliva will participate at the virtual European Biotech Investor Days, Hosted by Solebury Trout.
CEO Ellen Donnelly will be presenting the company on 7 April 2021, at 06:30 p.m. CEST.

Aktiedagen (virtual)
2021-03-16 | Virtual
Abliva will participate at Aktiespararna’s Aktiedagen (virtual) on 16 March 2021.
CEO Ellen Donnelly will be presenting the company at 6.30 p.m. CET.

BioStock Live
2021-03-09 | Virtual
Abliva will participate at the virtual BioStock Live on 9 March 2021.
CEO Ellen Donnelly will be presenting the company.
More information to come.

Swiss Nordic Bio 2021
2021-02-10 | Virtual
Abliva will attend the digital Swiss Nordic Bio 2021.
“Swiss Nordic Bio is a high-level partnering and investor conference aimed at connecting healthcare innovations, investor and industry.

The conference is the number one platform that gathers life science professionals from Switzerland and the Nordic countries under one roof.
The conference is organised by the Nordic countries in cooperation with Swiss partners.

Swiss Nordic Bio 2021 will be held on 10 February in digital format – the event will be live streamed and 1-to-1 meetings will be held virtually”.

J.P. Morgan 39th Annual Healthcare Conference 2021
2021-01-11 08:00 - 2021-01-14 17:00 | Virtual

Redeye Life Science Day
2020-11-27 08:30 - 16:30 | Virtual
CEO Erik Kinnman will be presenting the company at this virtual event.
